CORONAVIRUS NEWS
Over 600,000 people get first dose of Pfizer/BioNTech vaccine
The Government has published figures which show the number of people who have received the vaccine between 8 December and 20 December in the UK is 616,933.
Pregnant women excluded from three-quarters of COVID treatment trials
Pregnant women are among those most in need of safe, effective therapies against COVID-19, but they are routinely excluded from the majority of clinical treatment trials, according to authors of a paper, published in The Lancet Global Health journal.
New poll finds BAME groups less likely to want COVID vaccine
A new poll by the Royal Society for Public Health has revealed that three in four (76%) of the UK public would take a COVID-19 vaccine if advised to do so by their GP or health professional, with just 8% stating they would be very unlikely to do so.
Over 137,000 people receive first dose of COVID vaccine in one week
More than 137,000 people in the UK have received the first dose of the Pfizer/BioNTech COVID-19 vaccine in the first week of the largest vaccination programme in British history.
Machine learning helps develop more accurate COVID-19 diagnostic tool
Researchers at the University of Maryland, Baltimore County (UMBC) have developed a method of generating high-quality chest X-ray images that can be used to diagnose COVID-19 more accurately than current methods.
Portable digital chest drainage systems could minimise COVID spread
A team of thoracic consultants from Guy’s and St Thomas’ NHS Foundation Trust has uncovered important findings on the use of chest drains during the COVID pandemic.
Interim trial results published for Oxford vaccine
Interim results of the Oxford COVID-19 vaccine trials find that the vaccine protects against symptomatic disease in 70% of cases
Cancer risk factors for mortality following COVID
Cancer and cancer treatment are both independent risk factors for mortality following COVID-19 infection, according to UCLH led research which highlights the ongoing need to protect cancer patients during the pandemic.
COVID infections fall by over 50% in the North West and North East
Interim results from the seventh report of one of the country’s largest studies into COVID-19 infections in England have been published by Imperial College London and Ipsos MORI.
COVID-19: study highlights importance of early use of CPAP
The lives of patients hospitalised with COVID-19 are being saved by doctors who are using an existing medical treatment at an earlier stage.
Sheffield Trust chosen to lead major Covid-19 vaccine trial
Sheffield Teaching Hospitals NHS Foundation Trust is one of 17 sites across the country, and the only one in the Yorkshire and Humber, to have been selected to trial the latest Covid-19 candidate vaccine.
UCL steps up testing of immune response in care homes
The Vivaldi 2 study will more than triple in size to provide a detailed picture of coronavirus infection in care homes in England.
Beckman Coulter launches its SARS-CoV-2 IgM antibody test
Beckman Coulter has announced the launch of its Access SARS-CoV-2 Immunoglobulin M (IgM) assay in countries accepting the CE Mark.
UK ramps up vaccine manufacture capabilities
The Vaccines Manufacturing and Innovation Centre (VMIC) has announced rapid expansion of recruitment, in order to meet anticipated demand in 2021.
NHS response to the Prime Minister’s lockdown announcement
Responding to the Prime Minister’s statement on coronavirus, NHS Medical Director, Professor Stephen Powis, said: “Daily hospital COVID admissions are now higher than on 23 March when the Prime Minister announced the first national lockdown.
Imperial vaccine lead says COVID is here for years to come
Imperial’s COVID-19 vaccine lead, Professor Robin Shattock, has told MPs that there is uncertainty around the immunity that a vaccine will offer; boosting strategies may be required and we are likely to be living with the virus for years to come.
Research on blood pressure allays COVID fears
Fears that people with high blood pressure are more at risk from severe COVID-19 because it is easier for the virus to enter their cells and tissues have been laid to rest, thanks to research involving UCLH.
Antiviral drugs trialled in the early stages of COVID-19
Two antiviral drugs are being given to COVID-19 positive adults to establish if they stop the virus replicating, as part of a trial led by UCL scientists.
UK guideline on management of the long-term effects of COVID-19
NICE, the Scottish Intercollegiate Guidelines Network (SIGN) and the Royal College of General Practitioners (RCGP) have given more details about the forthcoming guideline on post-COVID syndrome which is due to be published by the end of the year.
Study shows myocarditis linked to COVID-19 not as common as believed
A new study suggests myocarditis caused by COVID-19 may be a relatively rare occurrence.
Featured Supplier
MARLUX is a global innovator of disposable privacy curtains for healthcare environments. Pioneering one of the world’s first disposable privacy curtains in 2003, today we continue to lead the way in our industry.
Upcoming Events
Central Sterilising Club Annual Scientific Meeting
Crowne Plaza, Newcastle Upon Tyne
3rd - 4th April 2023
DECON UK 2023
Hilton Birmingham Metropole
18th April 2023
Infection Prevention and Control 2023
National Conference Centre, Birmingham
25th - 26th April 2023
Access the latest issue of Clinical Services Journal on your mobile device together with an archive of back issues.
Download the FREE Clinical Services Journal app from your device's App store
